Introduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...
Read moreThe study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...
Read moreIntroduction Early Access Programs, also known as special access programs, give patients access to m...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe report looks at how differences in cancer survival rates between the UK and other countries have...
Read moreThe draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...
Read morePatients in England will be the first in Europe to have access to Takeda’s Exkivity (mobocertinib)...
Read moreAmgen’s Lumykras (sotorasib) has become the first active new technology to come through the Innova...
Read moreAccording to the National Agency for Drug Safety, there are currently four treatments available thro...
Read more14 new orphan drugs were made available in the national health service (Sistema Nacional de Salud, S...
Read more